![]() |
Volumn 19, Issue 2, 2011, Pages 771-782
|
Effect of structurally constrained oxime-ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists
|
Author keywords
Metabolic syndrome; Oxazole; Oxime; PPAR agonist; PPAR pan agonist; Thiazole
|
Indexed keywords
(2 METHYL 4 [1 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) THIAZOL 5 YLMETHOXYIMINO] ETHYL] PHENOXY) ACETIC ACID;
2 [2 METHYL 4 [ [((4 METHYL 2 (4 (TRIFLUOROMETHYL) PHENYL)THIAZOL 5 YL)METHOXY)IMINO]BUTYL]PHENOXY]ACETIC ACID;
2 [2 METHYL 4 [1 [((4 METHYL 2 (4 (TRIFLUOROMETHYL) PHENYL)THIAZOL 5 YL)METHOXY)IMINO]PROPYL]PHENOXY]ACETIC ACID;
2 [2 METHYL 4 [1 [((5 METHYL 2 (4 TOLYL))OXAZOL 4 YL) METHOXY)IMINO]BUTYL]PHENOXY]ACETIC ACID;
2 [2 METHYL 4 [1 [((5 METHYL 2 (4 TOLYL))OXAZOL 4 YL) METHOXY)IMINO]ETHYL]PHENOXY]ACETIC ACID;
2 [2 METHYL 4 [1 [((5 METHYL 2 (4 TOLYL))OXAZOL 4 YL) METHOXY)IMINO]PROPYL]PHENOXY]ACETIC ACID;
2 [2 METHYL 4 [1 [((5 METHYL 2 PHENYLOXAZOL 4 YL) METHOXY)IMINO]BUTYL]PHENOXY]ACETIC ACID;
2 [2 METHYL 4 [1 [((5 METHYL 2 PHENYLOXAZOL 4 YL) METHOXY)IMINO]ETHYL]PHENOXY]ACETIC ACID;
2 [2 METHYL 4 [1 [((5 METHYL 2 PHENYLOXAZOL 4 YL) METHOXY)IMINO]PROPYL]PHENOXY]ACETIC ACID;
2 [4 (1 [[(4 METHYL 2 (4 (TRIFLUOROMETHYL)PHENYL) THIAZOL 5 YL)METHOXY)IMINO]PROPYL]PHENOXY]ACETIC ACID;
2 [4 (1 [[(5 METHYL 2 PHENYLOXAZOL 4 YL)METHOXY) IMINO]ETHYL]PHENOXY]ACETIC ACID;
2 [4 (1 [[(5 METHYL 2 PHENYLOXAZOL 4 YL)METHOXY) IMINO]PROPYL]PHENOXY]ACETIC ACID;
2 [4 [1 [((4 METHYL 2 (4 (TRIFLUOROMETHYL)PHENYL) THIAZOL 5 YL)METHOXY)IMINO]ETHYL]PHENOXY]ACETIC ACID;
2 [4 [1 [((5 METHYL 2 (4 TOLYL)OXAZOL 4 YL)METHOXY) IMINO]ETHYL]PHENOXY]ACETIC ACID;
2 [4 [1 [((5 METHYL 2 (4 TOLYL)OXAZOL 4 YL)METHOXY) IMINO]PROPYL]PHENOXY]ACETIC ACID;
2 [4 [CYCLOHEXYL[((4 METHYL 2 (4 (TRIFLUOROMETHYL) PHENYL)THIAZOL 5 YL)METHOXY)IMINO]METHYL]PHENOXY]ACETIC ACID;
2 [4 [CYCLOHEXYL[((5 METHYL 2 (4 TOLYL)OXAZOL 4 YL) METHOXY)IMINO]METHYL] 2 METHYLPHENOXY]ACETIC ACID;
2 [4 [CYCLOHEXYL[((5 METHYL 2 PHENYLOXAZOL 4 YL) METHOXY)IMINO]METHYL] 2 METHYLPHENOXY]ACETIC ACID;
[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID;
ANTIDIABETIC AGENT;
ANTILIPEMIC AGENT;
BEZAFIBRATE;
OXAZOLE DERIVATIVE;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;
PIRINIXIC ACID;
ROSIGLITAZONE;
TESAGLITAZAR;
THIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
CELL STRAIN HEPG2;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
FEMALE;
GLUCOSE BLOOD LEVEL;
HAMSTER;
IN VITRO STUDY;
IN VIVO STUDY;
MALE;
MOUSE;
NONHUMAN;
TRIACYLGLYCEROL BLOOD LEVEL;
ANIMALS;
CRICETINAE;
DISEASE MODELS, ANIMAL;
ETHER, ETHYL;
HEP G2 CELLS;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MICE;
MICE, OBESE;
OXIMES;
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;
PPAR ALPHA;
PPAR DELTA;
PPAR GAMMA;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZOLES;
ANIMALIA;
|
EID: 78651496725
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.12.023 Document Type: Article |
Times cited : (16)
|
References (34)
|